Pages that link to "Q40851117"

The following pages link to Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome (Q40851117):

Displaying 47 items.

• Retroviral oncogenes: a historical primer (Q24611142) (← links)
• Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification (Q28299667) (← links)
• Isochromosome breakpoints on 17p in medulloblastoma are flanked by different classes of DNA sequence repeats (Q29037387) (← links)
• Advances in treatment of pediatric brain tumors (Q33237311) (← links)
• Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cells (Q33270402) (← links)
• c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients (Q33821504) (← links)
• Mutation and expression analysis in medulloblastoma yields prognostic variants and a putative mechanism of disease for i17q tumors. (Q34108929) (← links)
• The myc oncogene: MarvelouslY Complex (Q34555987) (← links)
• Paediatric embryonic brain tumours. biological and clinical relevance of molecular genetic abnormalities (Q34578601) (← links)
• Classifying the medulloblastoma: insights from morphology and molecular genetics (Q34783428) (← links)
• Molecular analysis of the rhabdoid predisposition syndrome in a child: a novel germline hSNF5/INI1 mutation and absence of c-myc amplification (Q35189235) (← links)
• Gene amplification in PNETs/medulloblastomas: mapping of a novel amplified gene within the MYCN amplicon (Q35435104) (← links)
• Prognosis-related molecular markers in pediatric central nervous system tumors (Q35996275) (← links)
• Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: a report from the Children's Oncology Group (Q36010031) (← links)
• Molecular pathogenesis of childhood brain tumors (Q36021571) (← links)
• Recent advances in embryonal tumours of the central nervous system (Q36025403) (← links)
• Early recurrence in standard-risk medulloblastoma patients with the common idic(17)(p11.2) rearrangement (Q36048155) (← links)
• Molecular Diagnostics in Embryonal Brain Tumors (Q36619093) (← links)
• Clinical and molecular stratification of disease risk in medulloblastoma (Q36623667) (← links)
• WIP1 enhances tumor formation in a sonic hedgehog-dependent model of medulloblastoma (Q36714301) (← links)
• Inhibition of STAT3 expression and signaling in resveratrol-differentiated medulloblastoma cells (Q36730962) (← links)
• Cytogenetic prognostication within medulloblastoma subgroups (Q37627692) (← links)
• Childhood medulloblastoma: current status of biology and treatment (Q37713662) (← links)
• Molecular diagnostics of CNS embryonal tumors (Q37794829) (← links)
• Medulloblastoma: recurrence and metastasis (Q38233118) (← links)
• Imbalances of chromosome 17 in medulloblastomas determined by comparative genomic hybridisation and fluorescence in situ hybridisation (Q38462467) (← links)
• Identification of c-myc-dependent proteins in the medulloblastoma cell line D425Med (Q39525739) (← links)
• c-Myc downregulation: a critical molecular event in resveratrol-induced cell cycle arrest and apoptosis of human medulloblastoma cells (Q40275467) (← links)
• Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors (Q41681708) (← links)
• High-risk medulloblastoma: does c-myc amplification overrule histopathology? (Q41998966) (← links)
• Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastoma (Q43995999) (← links)
• Distinct patterns of human medulloblastoma dissemination in the developing chick embryo nervous system. (Q46012040) (← links)
• Medulloblastomas: a correlative study of MIB-1 proliferation index along with expression of c-Myc, ERBB2, and anti-apoptotic proteins along with histological typing and clinical outcome (Q46097967) (← links)
• Epigenetic repression of RASSF1A but not CASP8 in supratentorial PNET (sPNET) and atypical teratoid/rhabdoid tumors (AT/RT) of childhood (Q46722744) (← links)
• Novel oncogene amplifications in tumors from a family with Li-Fraumeni syndrome (Q47981289) (← links)
• Intense p53 staining is a valuable prognostic indicator for poor prognosis in medulloblastoma/central nervous system primitive neuroectodermal tumors (Q48807437) (← links)
• Cytogenetic and histopathologic studies of congenital supratentorial primitive neuroectodermal tumors: a case report (Q48882751) (← links)
• Low-level copy number changes of MYC genes have a prognostic impact in medulloblastoma. (Q55463984) (← links)
• Immunohistochemical markers for prognosis of average-risk pediatric medulloblastomas. The effect of apoptotic index, TrkC, and c-myc expression. (Q55473294) (← links)
• Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas--implications for tumor biology and potential clinical utility. (Q55474087) (← links)
• Variation in survival of children with central nervous system (CNS) malignancies diagnosed in Europe between 1978 and 1992: the EUROCARE study. (Q55474431) (← links)
• "Large cell/anaplastic" medulloblastomas: a Pediatric Oncology Group Study. (Q55474949) (← links)
• Are clinical parameters valuable prognostic factors in childhood primitive neuroectodermal tumors? A multivariate analysis of 105 cases. (Q55475895) (← links)
• Molecular genetic studies of chromosome 11 and chromosome 22q DNA sequences in pediatric medulloblastomas. (Q55476296) (← links)
• ATM in breast and brain tumors: a comprehensive review (Q58804970) (← links)
• Mapping of the breakpoints on the short arm of chromosome 17 in neoplasms with an i(17q) (Q77914958) (← links)
• Biology and therapy of malignant solid tumors in childhood (Q81086315) (← links)